Leukotrienes in Crohn's disease: effect of sulfasalazine and 5-aminosalicylic acid.
D000636:Aminosalicylic Acids / Q000494:pharmacology*; D003106:Colon / Q000187:drug effects / Q000378:metabolism; D003424:Crohn Disease / Q000188:drug therapy* / Q000378:metabolism; D015232:Dinoprostone; D006801:Humans; D066298:In Vitro Techniques; D007413:Intestinal Mucosa / Q000187:drug effects / Q000378:metabolism; D007975:Leukotriene B4 / Q000096:biosynthesis*; D019804:Mesalamine; D010452:Peptide Biosynthesis; D011458:Prostaglandins E / Q000096:biosynthesis; D012460:Sulfasalazine / Q000494:pharmacology*
D000636:Aminosalicylic Acids; D011458:Prostaglandins E; D007975:Leukotriene B4; D012460:Sulfasalazine; D019804:Mesalamine; D015232:Dinoprostone